The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison
- 1 April 2007
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 369 (9570), 1347-1355
- https://doi.org/10.1016/s0140-6736(07)60633-3
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Prophylaxis of Thrombotic and Embolic Events in Acute Ischemic Stroke With the Low-Molecular-Weight Heparin CertoparinStroke, 2006
- Venous Thromboembolism After Acute Ischemic StrokeStroke, 2004
- European Stroke Initiative Recommendations for Stroke Management – Update 2003Cerebrovascular Diseases, 2003
- Guidelines for the Early Management of Patients With Ischemic StrokeStroke, 2003
- Venous Thromboembolism After Acute StrokeStroke, 2001
- Low-Molecular-Weight Heparins and Heparinoids in Acute Ischemic StrokeStroke, 2000
- Medical and Neurological Complications of Ischemic StrokeStroke, 1998
- Measurements of acute cerebral infarction: a clinical examination scale.Stroke, 1989
- LOW-DOSE SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS AND PULMONARY EMBOLI FOLLOWING ACUTE STROKEAge and Ageing, 1986
- LOW-DOSE HEPARIN AS A PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKEThe Lancet, 1977